logo

Veterinary Drugs Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The Veterinary Drugs Market is segmented by Product Type (Anti-infectives, Anti-inflammatory, Parasiticides, Vaccines, Others), By Route of Administration and Geography.

Home Industry Reports Healthcare Veterinary Drugs Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - ...

Market Snapshot

CAGR
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 5.8 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

Veterinary drugs are the drugs used in the treatment of numerous diseases growing in animals. Veterinary drugs such as antibiotics, antimicrobials, antihistamines, antiprotozoals and hormones are developed in order to minimize the attack of harmful virus and bacterial parasites in animals.

According to American Pet Products Association (APPA), 67% percent of United States households own a pet and estimated that 78 million dogs and 85.8 million cats are owned in the United States. Therefore the presence of advanced cost-effective veterinary drugs and rising clinical animal researches are the key driving factors in the veterinary drug market.

Scope of the Report

As per the scope of the report veterinary drugs are used in the treatment of numerous diseases growing in animals. Veterinary drugs such as antibiotics, antimicrobials, antihistamines, antiprotozoals and hormones are developed in order to minimize the attack of harmful virus and bacterial parasites in animals.

By Product Type
Anti-infectives
Anti-inflammatory
Parasiticides
Vaccines
Other Types
By Route of Administration
Oral
Parenteral
Topical
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Parasiticides Segment is Expected to be a Fastest Growing Segment in the Veterinary Drugs Market

Parasites are organisms that survive by attacking pets and farm animals for nourishment and live in or on the body, benefiting from food and protection. Common parasites such as ticks, mosquitos and fleas live outside the body on the skin or hidden in an animal’s fur which not only harm the animal, they can quickly spread a disease outbreak. For instance, the Rift Valley Fever is an endemic zoonotic disease in Africa and the Middle East that costs producers USD 427 million every year.

Hence, owing to aforementioned factors, along with rise in prevalence of infectious diseases and increase in pet ownership, the parasiticides segment hold a significant market share and is anticipated to show similar trend over the forecast period.

Pet Ownership.png

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America is expected to hold a major market share in the global veterinary drugs market due to a rise in the prevalence of infectious diseases and the emergence of new technologies in this region. North America held the highest share and is also expected to continue dominating the market through the forecast period. Moreover, the introduction of new animal-related products and increasing adoption of animals is fueling the growth of the overall regional market to a large extent.

Veterinary Drugs Market 2

Competitive Landscape

The veterinary drug market is moderately consolidated and consists of several major players. In terms of market share, few of the major players are currently dominating the market. Some of the companies which are currently dominating the market are Bayer AG, Zoetis Animal Healthcare, Virbac S.A, Boehringer Ingelheim International GmbH, Ceva, Vetoquinol S.A, Merck Ltd, Elanco, Intervet Inc and Bimeda, Inc

vet drugs Landscape

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rise in Prevalence of Infectious Diseases

      2. 4.2.2 Emergence of New Technologies, especially in Biologics

    3. 4.3 Market Restraints

      1. 4.3.1 Lack of Veterinarians​

      2. 4.3.2 Use of Counterfeit Medicines​

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Product Type

      1. 5.1.1 Anti-infectives

      2. 5.1.2 Anti-inflammatory

      3. 5.1.3 Parasiticides

      4. 5.1.4 Vaccines

      5. 5.1.5 Other Types

    2. 5.2 By Route of Administration

      1. 5.2.1 Oral

      2. 5.2.2 Parenteral

      3. 5.2.3 Topical

    3. 5.3 Geography

      1. 5.3.1 North America

        1. 5.3.1.1 United States

        2. 5.3.1.2 Canada

        3. 5.3.1.3 Mexico

      2. 5.3.2 Europe

        1. 5.3.2.1 Germany

        2. 5.3.2.2 United Kingdom

        3. 5.3.2.3 France

        4. 5.3.2.4 Italy

        5. 5.3.2.5 Spain

        6. 5.3.2.6 Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. 5.3.3.1 China

        2. 5.3.3.2 Japan

        3. 5.3.3.3 India

        4. 5.3.3.4 Australia

        5. 5.3.3.5 South Korea

        6. 5.3.3.6 Rest of Asia-Pacific

      4. 5.3.4 Middle-East and Africa

        1. 5.3.4.1 GCC

        2. 5.3.4.2 South Africa

        3. 5.3.4.3 Rest of Middle-East and Africa

      5. 5.3.5 South America

        1. 5.3.5.1 Brazil

        2. 5.3.5.2 Argentina

        3. 5.3.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Bayer AG

      2. 6.1.2 Zoetis Inc.

      3. 6.1.3 Virbac S.A

      4. 6.1.4 Boehringer Ingelheim International GmbH (Merial)

      5. 6.1.5 Elanco

      6. 6.1.6 Ceva

      7. 6.1.7 Vetoquinol S.A

      8. 6.1.8 Bimeda, Inc (Bimeda Holdings PLC)

      9. 6.1.9 Merck & Co., Inc.

      2. *List Not Exhaustive

  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Veterinary Drugs Market market is studied from 2018 - 2026.

The Veterinary Drugs Market is growing at a CAGR of 5.8% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

Bayer AG, Zoetis, Elanco, Virbac S.A, Boehringer Ingelheim International GmbH (Merial) are the major companies operating in Veterinary Drugs Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!